Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic, Idiopathic

Explore clinical trials studying Purpura, Thrombocytopenic, Idiopathic. Study availability and eligibility vary by location and protocol.

322 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic, Idiopathic trial results

Completed

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04225156

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010037 Ocala, Florida, United States
  • Investigator Site 0010042 Iowa City, Iowa, United States
  • Investigator Site 0010040 Columbus, Ohio, United States
View all 87 locations
View Trial Details
Completed

A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

NCT03395210

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Bleeding and Clotting Disorders Institute- Site Number : 1087 Peoria, Illinois, United States
  • RCCA MC LLC- Site Number : 1091 Bethesda, Maryland, United States
  • Massachusetts General Hospital Cancer Center- Site Number : 1092 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center- Site Number : 1099 Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Completed

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

NCT06444477

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
Locations
  • AP-HP Hôpital Jean Verdier service de médecine interne Bondy, France
  • CHU de Clermont-Ferrand - service de médecine interne Clermont-Ferrand, France
  • AP-HP Hôpital Mondor service de médecine interne Créteil, France
  • AP-HP Hôpital Bicêtre service de médecine interne Le Kremlin-Bicêtre, France
View all 20 locations
View Trial Details
Completed

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

NCT06665308

Conditions
Adult Immune Thrombocytopenia, Autoimmune Diseases, Blood Coagulation Disorders, +18 more
Locations
  • USC Norris Comprehensive Cancer Center- Site Number : 8400002 Los Angeles, California, United States
  • Massachusetts General Hospital- Site Number : 8400001 Boston, Massachusetts, United States
  • University of Washington-Fred Hutchinson Cancer Center_Site Number: 8400003 Seattle, Washington, United States
  • Investigational Site Number: 8260001 London, London, City of, United Kingdom
View Trial Details
Completed

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

NCT04669600

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigational Site Number :8400001 Washington D.C., District of Columbia, United States
  • Investigational Site Number :8400002 Tamarac, Florida, United States
  • Investigational Site Number :2030002 Ostrava - Poruba, Czechia
  • Investigational Site Number :2760001 Essen, Germany
View Trial Details
Completed

The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

NCT05438875

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
Locations
  • Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren hospital Beijing, Beijing Municipality, China
  • Department of Hematology, Beijing Friendship Hospital, Capital Medical University Beijing, China
  • Department of Hematology, Beijing Hospital Beijing, China
View Trial Details

Related conditions